◆ 会议时间：2020年9月26日至28日 会议取消
◆ 会议地点：美国 西雅图/Seattle, Washington - Hyatt Regency Seattle
◆ 会议简介：
2020年第13届卵巢癌研究研讨会/双年会议将于2020年9月26日至28日在美国西雅图举行，会议由Rivkin卵巢癌研究中心与美国癌症研究协会(AACR)联合组织，每两年举办一次。研讨会的目的是召集来自世界各地不同学科和机构的临床医生和研究人员，以促进合作，推动卵巢癌研究领域的发展。会议旨在增进对卵巢癌的了解和认识，特别是针对初级研究人员；讨论卵巢癌研究领域的最新创新；并解决临床和研究界领导人迫切关注的问题。会议议题将包括：DNA修复及其机制；免疫肿瘤学；模型系统；新型疗法；预防和早期发现；罕见肿瘤。——未经本站许可，禁止复制摘录本站任何内容-领域国际医学会议网。
| Due to the impact of the COVID-19 pandemic, we have made the difficult decision to cancel the in-person 13th Biennial Ovarian Cancer Research Symposium presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research in 2020. Our top priority is the health and safety of the researchers, clinicians, and our local community of ovarian cancer survivors who typically attend. We are exploring and hope to instead host a Virtual Ovarian Cancer Research Seminar Series in the form of weekly presentations during September in honor of Ovarian Cancer Awareness Month. Registration is currently closed, and we will not be accepting abstracts. |
13TH BIENNIAL OVARIAN CANCER RESEARCH SYMPOSIUM
The goal of the Symposium is to bring together clinicians and researchers from across many disciplines and institutions worldwide in order to encourage collaborations toward advancing the field of ovarian cancer research. The conference seeks to enhance the understanding and knowledge of ovarian cancer, especially among junior investigators; discuss the most recent innovations in the field of ovarian cancer research; and address pressing concerns of the leaders in the clinical and research community.
SESSION TOPICS WILL INCLUDE:
- DNA Repair and Mechanisms
- Immuno-oncology
- Model Systems
- Novel Therapeutics
- Prevention and Early Detection
- Rare Tumors
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
